Recurrent prescription of sleep medication among primary care patients with type 2 diabetes: an observational study of real-world registry data ...

• Main Authors: Heikkala, Eveliina, Jokelainen, Jari, Mikkola, Ilona, Auvinen, Juha, Hagnäs, Maria
• Format: Article in Journal/Newspaper
• Language: unknown
• Published: figshare 2023
• Subjects: Medicine; Physiology; FOS Biological sciences; Pharmacology; Biotechnology; 39999 Chemical Sciences not elsewhere classified; FOS Chemical sciences; Cancer; Science Policy; 111714 Mental Health; FOS Health sciences; Rovaniemi
• Online Access: https://dx.doi.org/10.6084/m9.figshare.c.6593848.v1; https://springernature.figshare.com/collections/Recurrent_prescription_of_sleep_medication_among_primary_care_patients_with_type_2_diabetes_an_observational_study_of_real-world_registry_data/6593848/1

Abstract Background Little knowledge exists on the prevalence of recurrent sleep medication prescriptions among primary care patients with type 2 diabetes (T2D). Our aims were to examine the prevalence of recurrent sleep medication prescriptions and to elucidate the most often prescribed sleep medications in a Finnish primary care T2D population. Methods The study examined 4,508 T2D patients who consulted a primary health care center between 2011 and 2019 in Rovaniemi, Finland. All the data were retrieved from patient records, and recurrent sleep medication was defined as two or more prescriptions within the study period. We used the Chi-square and Kruskal–Wallis tests to compare patients who did and did not have recurrent sleep medication prescriptions. Results Altogether 28.1% of the T2D patients had been prescribed recurrent sleep medication. Benzodiazepine-like medication, melatonin, and mirtazapine were most often prescribed (to 56.9%, 44.4%, and 35.8%, respectively). Only 22.0% of the patients with ...